Sterling Law Holdings, LLC

Justice:

Justice:

More than a word, it's a commitment to helping people move forward with their lives after a compromising medical issue caused by a bad drug or faulty medical device.

Sterling Law Holdings, LLC is focused on identifying and pre-qualifying individuals who may be eligible to make claims against, and collect damages from, defendants in mass-tort personal injury cases. A mass tort is a civil lawsuit involving several plaintiffs filing under the same court. These plaintiffs have suffered severe injuries and can be from a variety of different sources – automotive product defects, medical devices, defective drugs, hazardous materials, etc.

Industry News

Potential Lawsuit: 3M Combat Arms Defective Earplugs Lawsuit News and Legal Information

In July 2018, the American multinational corporation 3M settled a whistleblower lawsuit brought by the federal government alleging that the company knowingly supplied defective Combat Arms Earplugs to the US military. 3M was accused of violating the False Claims Act by selling the defective earplugs, falsifying test results and not disclosing the design defect that exposed the armed forces in Iraq and Afghanistan from hearing loss during the period of 2003 to 2015.
Potential Lawsuit: Cryptocurrency Fraud Lawsuit News and Legal Information

Since the middle of 2018, cryptocurrency lawsuits alleging various forms of financial fraud have become increasingly common. In some ways, the story is familiar -- the price went up suddenly at the beginning of 2018, and then it crashed through the proverbial floor. The lawsuits followed.
Potential Lawsuit: Tennessee Employment Lawsuit News and Legal Information

Tennessee labor lawsuits allege violations of Tennessee employment laws including overtime pay, discrimination and harassment. Tennessee labor law sets out guidelines for overtime, meal and rest breaks and other wage & hour laws. Possible violations of Tennessee employment law include wrongful termination, retaliation and discrimination.
Potential Lawsuit: Tesla Stock Lawsuits Legal News and Lawsuit Information

On August 8, 2018, Elon Musk, high flying CEO of Tesla, Inc. tweeted to the world that he was considering taking Tesla private at $420 per share. He said he had the money. The price of the stock skyrocketed, trading was temporarily suspended and the SEC launched an investigation into potential price manipulation. The financing later appeared to have depended on inconclusive conversations with the Saudi government. Some securities lawyers began to consider the impact of Musk’s tweeting on Tesla stock investors, including those who might be invested through their 401k plans. Within a week of Musk’s surprise announcement, several investors had filed Tesla stock lawsuits, claiming that they had suffered financial losses as a result of market manipulation.
Potential Lawsuit: Vaginal Rejuvenation Lawsuit News and Legal Information

On July 30, 2018, the United States Food & Drug Administration (FDA) issued a formal warning to manufacturers of laser gynecological devices and patients who have undergone, or plan to undergo, treatment with such devices. The FDA initially cleared these “energy based” devices for the treatment of serious health conditions, including cancer and hysterectomies. However, after reviewing reports of problems and the results of several studies, the agency has issued a stern warning against the use of these devices for “off label” purposes—including vaginal rejuvenation. Although these devices have been approved for the treatment of serious health conditions, the FDA has not approved their use for the treatment of other conditions for which they are being used. Seven device manufacturers have been targeted with warning letters, and the FDA has requested their feedback before deciding what actions, including potential enforcement actions, are appropriate.
Potential Lawsuit: Cash America Pawn Wage & Hour Lawsuit News and Legal Information

A store manager at First Cash, Cash America Central or Cash America Pawn has filed an overtime complaint against the franchise chain. Plaintiff Mr. J. Martin East alleges he has been misclassified as exempt and that First Cash has failed and refused to pay him and those managers in similar positions overtime pay for hours worked over 40 in a work week.
Potential Lawsuit: Valsartan Cancer Risk Legal News and Lawsuit Information

The drug Valsartan (a generic version of Diovan), which is prescribed to treat high blood pressure and prevent heart failure, has been recalled worldwide after it was found to contain N-nitrosodimethylamine (NDMA), a known carcinogen. Valsartan contamination from a Chinese manufacturing plant may date back to 2012, potentially exposing many patients to Valsartan cancer risk, liver damage and tumors. It has been on the market for 15 years.
Potential Lawsuit: Insurance Company ER Services Denial Lawsuit Information

Several insurance companies are refusing to cover emergency room visits, telling their policy holders/patients that they must pay for emergency services if the insurer deems the ER visit “unnecessary”. This new policy began with Anthem Insurance Company, which decides whether to pay an emergency room bill based on a doctor’s diagnosis — not the reason the patient went to the hospital. Health experts say this new policy will scare patients away from emergency departments – patients who could potentially have a life-threatening condition. Insurance attorneys are filing complaints against such insurers, claiming they violate federal and state law.
Potential Lawsuit: Intragastric Balloon Surgery Lawsuits Legal News and Lawsuit Information

Intragastric balloon lawsuits are now taking shape after a dozen deaths were attributed to the recently-approved form of weight-loss surgery. As of June 2018, the Food and Drug Administration linked 12 deaths to the implantation of what appears to be a defective medical device. The most recent reports implicate the Orbera Intragastric Balloon, manufactured by Apollo Endosurgery Inc. and the Integrated Dual Balloon, which is manufactured by ReShape Lifesciences. Similar devices are manufactured by Obalon Therapeutics and Spatz Medical.
Settlement: Kellogg's Settles Unpaid Overtime Class Action for $16.8M

Washington, DC: A $16.8 million settlement has been reached in an unpaid overtime class action lawsuit pending against Kellogg's Co. If the preliminary settlement receives final approval it will end four years of litigation.
Settlement: $10M Settlement Proposed in Uber Gender And Race Discrimination Class Action

San Francisco, CA: A $10 million settlement has been agreed between Uber and plaintiffs in a discrimination class action lawsuit who alleged the ride share company did not pay its female software engineers and engineers of colour equitably compared with their male and white or Asian American peers.
Settlement: AbbVie to Pay $3M in Androgel MDL Settlement

Chicago, IL: AbbVie Inc, the maker of Androgel, will pay $3 million to settle a defective product personal injury lawsuit, brought by a man from Oregon who alleged that his use of the testosterone replacement therapy caused him to suffer a heart attack.The lawsuit is part of a multi-district litigation (MDL) against several makers of testosterone replacement therapies, including Eli Lilly & Co., Endo, Auxilium and GlaxoSmithKline.
Settlement: $45M Settlement Reached in Family Dollar Store Employment Discrimination Class Action Lawsuit

Charleston, NC: A $45 million settlement has been finalized ending an employment discrimination class action lawsuit brought by 37,000 former and current female managers for Family Dollar Store Inc. The plaintiffs alleged that Family Dollar Store paid them less than their male counterparts. The lawsuit was brought 15 years ago.
Settlement: Settlement Reached in Orbit Car Seat Class Action Lawsuit

San Francisco, CA: A settlement has been reached in a consumer fraud class action lawsuit against Orbit Baby, Inc, which alleges deceptive marketing practices on the parts of Orbit Baby, Inc. and The ERGO Baby Carrier, Inc.
Settlement: $1.51B Deal Agreed in Syngenta GMO Corn Seed MDL

Santa Cruz, CA: A $1.51 billion settlement has been agreed between Syngenta AG and a nationwide class of plaintiffs who allege the chemical company should have delayed the release of its genetically modified corn seed until Chinese authorities, who represent a major corn market for US farmers, approved importing the GMO corn.

Medical Injuries

Medical injuries come in all forms from side effects of prescription drugs to surgical devices and implants which cause harm.

Qualification

Qualification for a settlement requires rigorous medical and legal documentation showing proof of harm.

The Settlement

The settlement, obtaining justice for people, is the focus of Sterling and our lead counsel firms. Click for example settlements.

Login